MS4A1 encodes the B cell surface marker CD20, is a member of the MS4A gene family which has been identified as n potential biomarker for predicting immunotherapy sensitivity in patients with colon cancer (CC) and having potential applications in gene therapy to inhibit CC progression.69 Here, MS4A1 is linked to malignant colon neoplasm.